Article
HSD17B13 Couples Hepatocyte Lipid Metabolism to Stellate Cell Activation via TGFb-1 Signaling
2025-10-14
Abstract excerpt
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease driven by hepatocellular lipid overload, immune activation, and hepatic stellate cell (HSC)-driven fibrogenesis. Human genetic studies reveal that loss-of-function (LoF) variants in 17 beta-hydroxysteroid dehydrogenase 13 ( HSD17B13 ) confer robust protection against advanced fibrosis and cirrhosis, establishing HSD17B13 as a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 87095a6e-449f-5eb7-bd93-93c05a36445f
- DOI
- 10.1101/2025.10.14.682191
